scholarly journals Severity of COVID‐19 in pregnancy: A review of current evidence

2020 ◽  
Vol 84 (5) ◽  
Author(s):  
Lauren M. Kucirka ◽  
Alexandra Norton ◽  
Jeanne S. Sheffield
2008 ◽  
Vol 8 (1) ◽  
pp. 44-52 ◽  
Author(s):  
Tippi K Mak ◽  
Punam Mangtani ◽  
Jane Leese ◽  
John M Watson ◽  
Dina Pfeifer

2020 ◽  
pp. flgastro-2019-101371 ◽  
Author(s):  
Christian P Selinger ◽  
Catherine Nelson-Piercy ◽  
Aileen Fraser ◽  
Veronica Hall ◽  
Jimmy Limdi ◽  
...  

Inflammatory bowel disease (IBD) poses complex issues in pregnancy, but with high-quality care excellent pregnancy outcomes are achievable. In this article, we review the current evidence and recommendations for pregnant women with IBD and aim to provide guidance for clinicians involved in their care. Many women with IBD have poor knowledge about pregnancy-related issues and a substantial minority remains voluntarily childless. Active IBD is associated with an increased risk of preterm birth, low for gestation weight and fetal loss. With the exception of methotrexate and tofacitinib the risk of a flare outweighs the risk of IBD medication and maintenance of remission from IBD should be the main of care. Most women with IBD will experience a normal pregnancy and can have a vaginal delivery. Active perianal Crohn’s disease is an absolute and ileal pouch surgery a relative indication for a caesarean section. Breast feeding is beneficial to the infant and the risk from most IBD medications is negligible.


2019 ◽  
Vol 14 (2) ◽  
pp. 102-108 ◽  
Author(s):  
Sabrina Youash ◽  
Verinder Sharma

Background: Hypertensive disorders of pregnancy including gestational hypertension, preeclampsia and eclampsia are conditions that cause significant perinatal and maternal morbidity and mortality. </P><P> Objective: This is a systematic review of the current evidence examining the relationship between both depression and antidepressants on pregnancy-related hypertensive conditions. </P><P> Methods: In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) protocol, six databases were searched for articles published between January 1990 and December 2017 (PubMed, Embase, PsycINFO, Cochrane Database of Systematic Reviews, MEDLINE and ClinicalTrials. gov). Randomized control trials, cohort studies and case-control studies were included in this review. Studies that measured the following exposures were included: Antidepressant exposure or diagnosis of depression. Studies that measured the following outcomes were included: Gestational hypertension, preeclampsia or eclampsia. A combination of keywords, as well as Medical Subject Headings (MeSH) index terms, was used for three general categories: antidepressants, depression and hypertensive disorders of pregnancy. A total of 743 studies were identified and 711 were excluded based on relevance to the research question. Twenty studies were included in the final systematic review. </P><P> Results: Of the twenty relevant studies, ten specifically examined the relationship between depression and hypertension in pregnancy. Only two of these did not find a significant association. Of the ten studies that concentrated on antidepressant medications, all except one found an association with hypertension in pregnancy to varying degrees. </P><P> Conclusion: Review of the literature suggests a possible association between depression and antihypertensive medications with pregnancy-related hypertension, but further studies are needed.</P>


2019 ◽  
Vol 46 (3) ◽  
Author(s):  
Cayce Watson ◽  
April Mallory ◽  
Amy Crossland

Reducing harm, supporting autonomy, and affirming dignity are foundational values in social work practice.  Attempts to balance personal beliefs, faith, and ethical responsibilities with client-centered therapies can elicit internal conflicts for practitioners.  These challenges are even more evident when working with opioid dependent pregnant women in medication-assisted recovery.  Medication-assisted treatment (MAT) is evidence-based and a recommended first-line approach for treating opioid use disorder in pregnancy; however, neonates exposed to opiates, either street drugs or MAT, may develop neonatal abstinence syndrome (NAS).  Disagreement among treatment providers, insufficient resources for pregnant clients, and incomplete service delivery compound the stigma surrounding pregnant women living with opioid misuse.  This article explores current evidence and best practices for pregnant women with opioid use disorder, the spiritual and ethical dilemmas of social workers supporting a harm reduction approach, and recommendations for individual and community-based interventions that support the dignity and worth of both mother and baby.


2018 ◽  
Vol 10 (9) ◽  
pp. 585-594 ◽  
Author(s):  
Alberto Enrico Maraolo ◽  
Ivan Gentile ◽  
Antonio Riccardo Buonomo ◽  
Biagio Pinchera ◽  
Guglielmo Borgia

Sign in / Sign up

Export Citation Format

Share Document